Aortic stenosis (AS) is a progressive heart valve disease that leads to the narrowing of the aortic valve opening, restricting blood flow from the heart to the rest of the body.
Objective Multidisciplinary team (MDT) meetings are central to treatment decisions in aortic stenosis (AS), particularly for borderline or high-risk patients. This study evaluates long-term, ...
Valve-in-valve (ViV) transcatheter procedures for a failed aortic bioprosthesis are associated with a lower risk of in-hospital mortality compared with a repeat surgical aortic valve replacement, but ...
In patients with symptomatic severe aortic stenosis at intermediate or higher surgical risk, CoreValve or Evolut transcatheter aortic valve implantation (TAVI) was associated with a lower 5-year ...
Annual Meeting, investigators presented a late-breaking study focused on surgical aortic valve replacement (SAVR) following ...
Several medical societies supported extending Medicare coverage for TAVR to patients with asymptomatic aortic stenosis, but ...
PARIS, France—There is more than a twofold greater risk of death, and a significantly increased risk of major adverse cardiac events, over nearly 2 years of follow-up when patients with a bicuspid ...
COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc. today announced successful results in an additional 5 patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV™) ...
Thubrikar Aortic Valve, Inc. today announced authorization from the Competent Authority of Poland to expand the TAVI-1 CE Mark trial of the Optimum Transcatheter Aortic Valve Implantation System™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results